University of California, Davis
Internal Medicine residency · Sacramento, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of California, Davis's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About University of California, Davisinstitution-wide internal medicine research
Internal Medicine publications from University of California, Davis and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
731
works per year
47th of 129 internal medicine residency programs
-1.8%
2-year growth
103rd of 129 internal medicine residency programs
24.6%
in top 10% of field (works before 2025)
56th of 120 internal medicine residency programs
47.9%
cited above world average
47th of 120 internal medicine residency programs
Works per year · * 2026 so far
Pulmonary and Respiratory Medicine · 775Cardiology and Cardiovascular Medicine · 650Oncology · 456Infectious Diseases · 448Hematology · 240
Internal Medicine research topics at University of California, Davis
Papers in the window; each links to the list on OpenAlex.
- Cardiac electrophysiology and arrhythmias 196
- Veterinary Oncology Research 140
- Liver Diseases and Immunity 129
- Osteoarthritis Treatment and Mechanisms 96
- Atrial Fibrillation Management and Outcomes 80
- SARS-CoV-2 and COVID-19 Research 79
- Cancer Immunotherapy and Biomarkers 69
- Venous Thromboembolism Diagnosis and Management 68
Most cited at University of California, Davis since 2024
All internal medicine papers there on OpenAlex
- Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Patrick Barry Mark et al. · The Lancet · 2025 · PubMed · cited 587
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- A Phase 3 Trial of Seladelpar in Primary Biliary CholangitisGideon Morris Hirschfield et al. · New England Journal of Medicine · 2024 · PubMed · cited 292
- Long‐term follow‐up of VIALE‐A : Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemiaKeith William Pratz et al. · American Journal of Hematology · 2024 · PubMed · cited 249
- Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)Albert Do et al. · Nature Reviews Drug Discovery · 2024 · PubMed · cited 188
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidineHartmut Döhner et al. · Blood · 2024 · PubMed · cited 166
- Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal diseaseMartin Hoenigl et al. · Clinical Microbiology Reviews · 2024 · PubMed · cited 160
- Antithrombotic Therapy for VTE DiseaseScott M. Stevens et al. · CHEST Journal · 2024 · PubMed · cited 159
- The Role of Psychosocial Stress on Cardiovascular Disease in WomenImo Ebong et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 141